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Introduction: The observed association between depressive symptoms and cognitive
performances has not been previously clarified in patients with amyotrophic lateral
sclerosis (pALS). In fact, the use of cognitive measures often not accommodating for
motor disability has led to heterogeneous and not conclusive findings about this issue.
The aim of the present study was to evaluate the relationship between cognitive and
depressive/anxiety symptoms by means of the recently developed Edinburgh Cognitive
and Behavioral ALS Screen (ECAS), a brief assessment specifically designed for pALS.
Methods: Sample included 168 pALS (114 males, 54 females); they were administered
two standard cognitive screening tools (FAB; MoCA) and the ECAS, assessing different
cognitive domains, including ALS-specific (executive functions, verbal fluency, and
language tests) and ALS non-specific subtests (memory and visuospatial tests). Two
psychological questionnaires for depression and anxiety (BDI; STAI/Y) were also
administered to patients. Pearson’s correlation coefficient was used to assess the
degree of association between cognitive and psychological measures.
Results: Depression assessment negatively correlated with the ECAS, more
significantly with regard to the executive functions subdomain. In particular, Sentence
Completion and Social Cognition subscores were negatively associated with depression
levels measured by BDI total score and Somatic-Performance symptoms subscore.
Conversely, no significant correlations were observed between depression level and
cognitive functions as measured by traditional screening tools for frontal abilities
(FAB) and global cognition (MoCA) assessment. Finally, no significant correlations were
observed between state/trait anxiety and the ECAS.
Discussion and conclusion: This represents the first study focusing on the
relationship between cognitive and psychological components in pALS by means
of the ECAS, the current gold standard for ALS cognitive-behavioral assessment.
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If confirmed by further investigations, the observed association between depression
and executive functions suggests the need for a careful screening and treatment of
depression, to avoid overestimation of cognitive involvement and possibly improve
cognitive performances in ALS.
Keywords: depression, anxiety, executive functions, social cognition, ECAS, amyotrophic lateral sclerosis
INTRODUCTION
A consistent body of literature concerning cognitive-behavioral
alterations in amyotrophic lateral sclerosis (ALS) in the last
20 years allowed to recognize it as a multisystem disorder, and not
a purely motor neuron disease. In particular, specific cognitive
alterations have been described, together with psychological and
behavioral changes, with underlying uncompletely determined
patterns of neuroradiological, neurobiological, and genetic
profiles (DeJesus-Hernandez et al., 2011; Phukan et al., 2012;
Goldstein and Abrahams, 2013; Agosta et al., 2016). A prevalence
of 30–50% of cognitive impairment, predominantly in the form
of executive dysfunction, has been described (Phukan et al., 2012;
Montuschi et al., 2015); in about 10–15% of ALS patients these
changes fulfill the criteria for frontotemporal dementia – FTD
(Phukan et al., 2012; Goldstein and Abrahams, 2013; Montuschi
et al., 2015). Prevalence rates for depression and anxiety in ALS
range from 0 to 44% and from 0 to 30%, respectively (Kurt et al.,
2007). Both psychological aspects and cognitive changes exert a
well-known effect on quality of life, functional abilities, prognosis
and survival of patients with ALS (pALS) (Elamin et al., 2013;
van Groenestijn et al., 2016; Xu et al., 2017). An association
between cognitive deficits and depression has been consistently
observed in both clinical and medically healthy populations (Lim
et al., 2013; Rock et al., 2014; Pu et al., 2017; Yoon et al.,
2017). In particular, depressive symptoms seem to primarily affect
executive functioning, with neuroimaging findings supporting
the involvement of brain networks entailing frontal-subcortical
circuits in depressed patients (Rock et al., 2014; Ahern and
Semkovska, 2016; Brakowski et al., 2017).
Despite the presence of consistent evidence in other
neurological diseases (e.g., Terroni et al., 2012; Nunnari et al.,
2015; Snowden et al., 2015), the association between cognition
and psychological aspects has been poorly investigated in
ALS, also showing conflicting results. A recent study revealed
the absence of a relation between cognitive impairment and
psychiatric/psychosocial measures, as well as between cognitive
impairment and wish to die, employing a neuropsychological
assessment focused on executive functions (Rabkin et al.,
2016). On the contrary, other studies adopting different
measures of cognitive functions showed an association
between psychological/psychiatric symptoms and global
cognition (Wei et al., 2016) and between depression and
specific neuropsychological aspects, including verbal and visual
learning, processing speed and language (Jelsone-Swain et al.,
2012).
When considering more innovative cognitive tools, two
recent studies about feasibility of Eye-Tracking (ET) and Brain
Computer Interface (BCI) technologies for cognitive testing in
ALS highlighted a negative correlation between anxiety levels and
reasoning time at some neuropsychological tests for executive
functions. Such results were interpreted according to an increase
in the rate of impulsivity, possibly depending both on the reduced
amount of cognitive and inhibitory resources in pALS and on
the supplementary influence of anxiety on such cognitive profile
(Poletti et al., 2016a,b). In both studies, no significant correlations
were observed between ET tests and depression level, as measured
by Beck Depression Inventory (Beck et al., 1961).
A relevant issue in the neuropsychological assessment
of pALS concerns the absence of validated gold standard
tools, accommodating for progressive physical disabilities and
providing reliable, comprehensive and comparable results across
studies. This aspect remained an unsolved issue till the recent
development (Abrahams et al., 2014), and validation into
several languages (Lulé et al., 2015; Niven et al., 2015; Poletti
et al., 2016c) of a rapid multi-domain cognitive-behavioral
screening tool specifically designed for ALS, i.e., the Edinburgh
Cognitive and Behavioral ALS Screen – ECAS. Moreover,
the ECAS has been specifically designed to accommodate for
verbal/motor disability, since subtests can be administered
both in spoken and written form and in moderate/advanced
stages of the disease. Despite the rapid and large diffusion
of such screening tool for the clinical assessment of pALS,
it has never been applied in order to specifically investigate
the association between cognitive and psychological aspects.
Only two studies report the use of the ECAS in association
to psychological and behavioral scales, without specifically
addressing such topic. In particular, Radakovic et al. (2017)
described the absence of correlation between depression
evaluated by means of Geriatric Depression Scale and ‘cognitive
functioning task performances’ including the Verbal Fluency
Total Score of the ECAS. Another study (Niven et al., 2015)
described the absence of correlations between anxiety and ECAS
scores, but no indications were provided about symptoms of
depression.
In the context of the validation of the Italian ECAS, we
preliminarily explored the relationship between such instrument
and psychological variables such as anxiety and depression
(Poletti et al., 2016c). In the recruited sample, a mild negative
association was observed between depression assessment and
both global and ALS-specific functions scores at the ECAS;
moreover, state anxiety assessment negatively correlated with the
ECAS total and the ALS non-specific functions scores.
As above described, previous literature data on other
medically ill and non-medically ill populations (Terroni et al.,
2012; Lim et al., 2013; Rock et al., 2014; Nunnari et al., 2015;
Snowden et al., 2015; Pu et al., 2017; Yoon et al., 2017) supports
the presence of a relationship between a psychological aspect,
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i.e., presence/severity of depressive symptoms and cognitive
profiles. Basing on such evidence, as well as on conflicting results
regarding pALS and on our preliminary findings, we aimed to
investigate the association between psychological features and
cognitive abilities with the ECAS in a larger ALS population,
particularly focusing on executive functions. Such association was
also investigated with traditional cognitive measures of frontal
(FAB) and global cognitive functioning (MoCA) not specifically
designed for ALS, in order to identify possible differences
between the gold standard ALS instrument and traditional
cognitive tools for such purposes.
The presented research is part of a larger and ongoing clinical
study using the ECAS for longitudinal assessment, evaluating its
feasibility and sensitivity across the course of ALS disease.
MATERIALS AND METHODS
Participants
Sample included 168 ALS patients (Males: 114; Females: 54;
age: 62.3 ± 12.1 years; education: 11.1 ± 4.4 years; disease
duration: 33.6 ± 42.7 months) recruited at the Department of
Neurology, IRCCS Istituto Auxologico Italiano. The diagnosis
of ALS was made by neurologists experienced in the field of
neuromuscular diseases, with patients fulfilling the revised El
Escorial criteria for clinically possible, probable, probable –
laboratory-supported or definite ALS (Brooks et al., 2000).
Patients in terminal stages of disease or with major comorbid
medical, neurological or cardio-vascular diseases were excluded
from the study. Disease status was evaluated using the ALS
Functional Rating Scale-Revised – ALSFRS-R (Cedarbaum
et al., 1999). The study protocol was reviewed and approved
by the Ethics Committee of our Institution and all eligible
subjects received verbal and written information about the
study. All participants signed an informed consent, according
to the Declaration of Helsinki. Patients performed the designed
cognitive and psychological protocol, as described below; it
was administered by trained neuropsychologists and required
approximately 40 min.
Cognitive and Psychological Assessment
Cognitive Assessment
A neuropsychological and psychological protocol employed in
a previous study (Poletti et al., 2016c) was adopted, including
both two standard cognitive measures and a recently validated
rapid cognitive-behavioral screening tool specifically developed
for ALS (Edinburgh Cognitive and Behavioral ALS Screen –
ECAS).
The Italian version of the ECAS was administered, assessing
different cognitive domains, including ALS-specific (executive
functions, fluency and language tests) and ALS non-specific
domains (memory and visuospatial functions tests). Each domain
includes specific tests (see Table 1). Moreover, it involves a
separate Carer Interview, investigating behavior and psychotic
alterations.
Standard cognitive measures included two brief batteries;
for frontal executive functions, Frontal Assessment Battery –
TABLE 1 | pALS’ scores at the standard cognitive screening and the ECAS.
Mean ± SD Range Cut-off
FAB (n = 149) 15.81 ± 1.68 10–18 13.4
MoCA (n = 143) 22.78 ± 2.86 14–30 17.36
ECAS total score (n = 168) 99.67 ± 18.73 31–129 97
ALS specific functions 73.24 ± 15.12 21–97 71
Language functions 23.30 ± 4.19 9–28 22
Naming 6.64 ± 1.59 0–8 –
Comprehension 7.57 ± 0.83 4–8 –
Spelling 9.09 ± 2.83 0–12 –
Fluency 16.01 ± 5.75 0–24 14
Fluency letter S 8.39 ± 3.01 0–12 –
Fluency letter C 7.62 ± 3.57 0–12 –
Executive functions 33.93 ± 7.59 9–47 31
Reverse digit span 5.32 ± 1.87 0–11 –
Alternation 9.70 ± 3.36 0–12 –
Sentence completion 9.36 ± 2.56 0–12 –
Social cognition 9.55 ± 2.97 1–12 –
ALS non-specific functions 26.43 ± 5.00 10–34 24
Memory functions 15.05 ± 4.59 1–22 13
Immediate recall 5.24 ± 2.10 0–9 –
Delayed retention 7.69 ± 2.68 0–10 –
Delayed recognition 2.11 ± 1.26 0–4 –
Visuospatial functions 11.38 ± 1.02 6–12 10
Dot counting 3.90 ± 0.30 3–4 –
Cube counting 3.58 ± 0.80 1–4 –
Number location 3.90 ± 0.39 1–4 –
Data are expressed as Means ± SD or absolute numbers.
FAB (Dubois et al., 2000) was employed, evaluating subdomains
of conceptualization, mental flexibility, motor programming,
sensitivity to interference, inhibitory control, and environmental
autonomy; for global cognitive functioning, Montreal Cognitive
Assessment – MoCA (Italian translation by Pirani et al.,
2007; Italian normative data by Conti et al., 2014) was
administered.
Psychological Assessment
The evaluation of depressive and anxiety symptoms was
performed by means of two self-rated measures widely used
in ALS, i.e., the Beck Depression Inventory (BDI) (Beck et al.,
1961) and State-Trait Anxiety Inventory-Y (STAI-Y) (Spielberger
et al., 1970), for both state (STAI-Y1) and trait (STAI-Y2)
anxiety components assessment. The BDI consists of 21 items,
concerning both cognitive-affective (BDI CA, items 0–13)
and somatic-performance (BDI SP, items 14–21) symptoms
of depression. Total score ranges from 0 to 63, with higher
total scores indicating more severe depressive symptoms. The
standard cut-off ranges are as follows: 0–9 indicates minimal
depression, 10–18 indicates mild depression, 19–29 indicates
moderate depression, 30–63 indicates severe depression. The 40-
item STAI-Y scores range from 20 to 80. Questions refer to how
anxious people are feeling at the time of the study (state) and in
general (trait). Scores higher than 65 indicate a clinically relevant
anxiety.
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Statistical Analysis
Descriptive statistics (mean± standard deviations for continuous
variables and absolute number and frequencies for discrete
variables) were used to describe the main characteristics
of our sample and performances obtained at the ECAS
and at standard cognitive/psychological assessments. Pearson’s
correlation coefficient was used to assess the degree of association
between measures. An α level of 0.05 was used for all hypothesis
tests. P-values were adjusted with a ‘False Discovery rate’
approach for multiple comparison correction (Benjamini and
Hochberg, 1995). All data analyses were performed using SAS 9.2
software (SAS Institute, Cary, NC, United States).
RESULTS
Patients’ Demographic and Clinical
Characteristics
Clinical neurological examination showed a mean ALSFRS/R
score of 37.2 ± 7.5 (ALSFRS/R Bulbar: 10.2 ± 2.3); 51 patients
presented upper limb regions involvement at onset, 70 lower
limb regions, 9 upper and lower limb, 35 bulbar, 2 bulbar
and lower limb and one respiratory symptoms at onset. Ten
patients had non-invasive ventilation (NIV) and no one had
percutaneous endoscopic gastrostomy (PEG). For description
of patients’ scores at ECAS and standard cognitive screening
measures, see Table 1.
With regard to psychological aspects, of the 154 patients
who completed the BDI, one hundred (65%) showed a clinically
significant depression, ranging from mild-to-moderate (43%),
moderate-to-severe (17%) and severe (5%). Of the 155 patients
who completed the STAI-Y, 13 (8%) showed a clinically
significant state anxiety and 15 (10%) showed relevant trait
anxiety levels. See Table 2 for description of patients’ scores at
the psychological assessment.
Relationship of Psychological Symptoms
to ECAS Scores and Subdomains
Analysis of association between cognitive and depression scores
revealed the presence of significant, even if modest, correlations
between variables. In particular, depression assessment negatively
correlated with the ECAS Total and the ALS-Specific functions
scores, mainly with regard to Somatic-Performance symptoms
TABLE 2 | pALS’ scores at the psychological assessment.
Mean ± SD Range
Beck Depression Inventory (BDI) (n = 154)
Total score 14.13 ± 8.84 1–58
Cognitive-affective symptoms 6.49 ± 5.95 0–41
Somatic-performance symptoms 7.64 ± 3.92 0–18
State-Trait Anxiety Inventory (Form Y) (n = 155)
State anxiety – Y1 (T-score) 49.46 ± 9.47 34–76
Trait anxiety – Y2 (T-score) 50.92 ± 10.25 30–80
Data are expressed as Means ± SD or absolute numbers.
and BDI Total score (BDI SP-ECAS Total score: r = −0.21,
p = 0.023; ALS-Specific functions score: r =−0.22, p = 0.019; BDI
Total score-ECAS Total score: r = −0.22, p = 0.019; ALS-Specific
functions score: r = −0.23, p = 0.019; BDI CA-ECAS Total score:
r = −0.19, p = 0.028; ALS-Specific functions score: r = −0.19,
p = 0.027). No significant correlations were observed between
anxiety and the ECAS, concerning both Total score and ALS-non
Specific/Specific functions.
Analysis performed on the ECAS subdomains revealed mild
significant, negative correlations between the ECAS executive
functions subdomain and both Cognitive-Affective and Somatic-
Performance symptoms of depression (BDI CA-ECAS executive
functions: r = −0.21, p = 0.023; BDI SP-ECAS executive
functions: r = −0.24, p = 0.017). Moreover, negative correlations
were also observed between BDI total score and Executive
functions subdomains as well as Language (BDI Total score-
ECAS Language: r = −0.20, p = 0.023; ECAS executive functions:
r = −0.25, p = 0.016). Language subdomain also correlated with
Cognitive-Affective BDI subscore (r = −0.19, p = 0.027).
Relationship of Psychological Symptoms to Specific
Cognitive Tests of the ECAS Subdomains
Further analysis performed on cognitive tests included in the
subdomains revealed that, with regard to executive functions
subdomain, Sentence Completion and, particularly, Social
Cognition were associated with depression levels measured by
BDI total score and Somatic-Performance symptoms scores (BDI
SP-Sentence Completion: r = −0.22, p = 0.019; Social Cognition:
r = −0.29, p = 0.007; BDI Total score-Sentence Completion:
r =−0.20, p = 0.023; Social Cognition: r =−0.26, p = 0.016). Mild
correlations were also observed between Cognitive-Affective BDI
subscore and Social Cognition (r = −0.19, p = 0.028). Moreover,
BDI Total Score negatively correlated with performance at the
Spelling test (BDI Total score-Spelling: r = −0.20, p = 0.028).
Finally, significant but weak correlations were also observed
between depression scores and Immediate Recall subtest within
the Memory subdomain (BDI SP – Immediate recall: r = −0.16,
p = 0.044; BDI Total Score-Immediate Recall: r = −0.18,
p = 0.029).
Relationship of Psychological Symptoms
to Performance at Standard Cognitive
Screening Tools
No significant correlations were observed between depression
assessment (BDI), concerning both total, cognitive-affective and
somatic-performance symptoms, and traditional screening of
frontal abilities (FAB) and global cognition (MoCA). Similarly,
anxiety assessment (STAI-Y) did not correlated with either FAB
or MoCA for neither state or trait anxiety scores.
DISCUSSION
This study revealed the presence of mild significant correlations
between depression scores and the ECAS, mainly concerning the
executive functions subdomain. Such findings are in accordance
with previous literature regarding patients with depression
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without neurological illness. In particular, some recent reviews
and meta-analysis about cognitive impairment in depressed
patients showed that depression is related to reduction in a wide
range of cognitive abilities, including attention, processing speed,
executive function, and memory (Lim et al., 2013; Bortolato
et al., 2014; Ahern and Semkovska, 2016); in particular, larger
impairments were observed in executive abilities concerning
processing speed and shifting, while memory scores were affected
by small to moderate impairments (Ahern and Semkovska, 2016).
A recent review on adult individuals with depression focusing
on studies employing neuropsychological tests for executive
functions showed that the majority of studies included (25 of
28) found alterations in some aspects of executive functioning
in patients with depression (Alves et al., 2014). Moreover,
deficit in executive functions and attention seem to persist after
remission of depressive symptoms, in particular with regard to
inhibition, shifting and verbal fluency (Rock et al., 2014; Ahern
and Semkovska, 2016).
In our sample, more detailed analysis within the executive
functions subdomain revealed a more significant involvement of
social cognition abilities in association with depression scores.
Such finding is in agreement with literature underling a positive
relationship between severity of depression symptoms and degree
of Theory of Mind (ToM) impairments in depressed patients
(Cusi et al., 2013; Bora and Berk, 2016). In a recent meta-
analysis, ToM deficits were not influenced by severity of executive
dysfunctions, suggesting that social cognition impairment could
represent a separate domain affected in depressive disorders,
aside with executive functions (Bora and Berk, 2016). Debate
is still open about the source of social cognition deficits
in ALS as studies provide heterogeneous results about their
independence from executive dysfunction (Consonni et al.,
2016; Strong et al., 2017). Another possible explanation is
the one considering the inhibitory component as specifically
associated to depression symptoms in ALS, resembling what
described in depressed patients without neurological illness
(Alves et al., 2014). In our sample, such consideration is
supported by the association between depression scores and
tasks markedly involving inhibitory abilities, i.e., Sentence
Completion and Social Cognition within the Executive Functions
subdomain.
Weak correlations have been observed in our sample between
memory subdomain, in particular the Immediate Recall test, and
depression scores. The involvement of memory functions, in
particular immediate recall, cannot be clearly separated by the
influence of attention and executive alterations, since available
cognitive tests, and also those included into the ECAS, are usually
related to both cognitive domains. In ALS population, the lack
of consensus about the characterization of memory alterations
and the poor specificity of such components leaded to not
include them in the current criteria for ALS-FTD (Strong et al.,
2017). Therefore, the collected data do not actually support an
association between depression and memory function in our
sample, also according to the weak correlations recorded.
Mild correlations have also been observed between the
Spelling test within the language subdomain and depression
score. Such data, not confirmed by available literature, needs
further investigations and more significant data to be more
critically considered.
Only few studies have investigated the association between
depression symptoms and cognition in pALS. With regard
to available literature in this field, our data are globally in
accordance with two previous studies (Jelsone-Swain et al.,
2012; Wei et al., 2016), highlighting an effect of depressive
symptoms on cognitive performance at both global and specific
neuropsychological measures in ALS. Conversely, contrasting
results have been observed in other previous studies employing
both traditional and motor-verbal free cognitive testing, showing
the absence of a relationship between cognitive impairment and
depression levels (Poletti et al., 2016a,b; Rabkin et al., 2016).
The novelty of such topic in ALS, in association with the variety
of measures for depression and cognition employed and the
different modes of administration of neuropsychological tests
(both ‘paper and pencil’ and motor-verbal free based measures),
makes a comparison with previous findings not feasible. Possibly,
the increasing adoption of a recently validated gold standard
measure for cognition and behavior in ALS, i.e., the ECAS, will
allow to provide comparable data across studies and to realize
longitudinal investigations, due to the partial compensation of
motor disability. Moreover, the absence of correlations observed
between depression scores and performance at standard cognitive
screening tools (FAB and MoCA) further support the use of the
ECAS for the investigation of the discussed topic according to
both sensitivity and feasibility components of such instrument
in ALS. In our sample, association with cognition mainly
concerned Total BDI Score and Somatic-Performance BDI
components, while Cognitive-Affective components were only
poorly associated with cognitive scores. These results could be
controversial, according to doubts that BDI may overestimate
the presence of depression in ALS, since it contains a number
of somatic/vegetative symptoms that can overlap with physical
illness. However, the use of BDI in our protocol is consistent with
previous studies that confirmed the reliability of such measure in
pALS. A previous study comparing the estimated prevalence of
depression using BDI and a questionnaire specifically designed
for pALS revealed little discrepancy between findings (Kubler
et al., 2005). Also the use of a modified BDI scale, without items
that could be confounded by physical symptoms, showed good
agreement with the standard BDI scale (Wicks et al., 2007).
Therefore, the BDI score can be considered appropriate for
clinical use in ALS population (Kubler et al., 2005; Wicks et al.,
2007; Taylor et al., 2010).
In depressed patients, both somatic/vegetative symptoms and
negative affective states/dysfunctional cognitive patterns may
interfere with optimal performance. According to our results,
we could hypothesize that in pALS the influence of depression
over cognition, in particular social cognition abilities, may be
more specifically mediated by somatic/vegetative symptoms. If
confirmed by further studies, this result could be discussed
within the frame of psychophysiological changes, involving the
sympathetic nervous system, observed in ALS in association to
social and emotional impairments (Lulé et al., 2005).
With regard to another psychological components
investigated, i.e., state and trait anxiety, we found not significant
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associations with cognitive performances at the ECAS. According
to recent literature, experimentally induced anxiety seems
to impair performance only under low-load, i.e., simple
cognitive tasks, while its effect is reduced when subjects
engage in more difficult tasks that involve high attentional
and executive resources (Vytal et al., 2012, 2013). Previous
results obtained in ALS underlined an effect of anxiety on
reasoning times, with higher levels of anxiety corresponding
to lower execution times at some cognitive tests (Poletti
et al., 2016a,b). In our sample, the limited proportion of
patients presenting with clinically relevant state and trait
anxiety levels, with global mean scores considerably lower
than cut off, could explain the absence of clear effects of
such psychological component over the observed performances.
Moreover, previously reported associations between anxiety and
execution times would not have been observed with the employed
protocol that not include time-related measures. Therefore,
further investigations are needed in ALS in order to clarify such
issue.
Limitations of the present study mainly concern the
psychological evaluation of pALS. In particular, informations
about previous depressive episodes that could have helped
in distinguishing between recurrent depressive episodes and
depressive symptoms reactive to ALS diagnosis have not been
systematically collected and described. Moreover, exclusion
of patients taking psychotropic drugs, or distinction of such
subgroup for data analysis, would have been useful to prevent
or highlight the potential effect of medications on cognitive
performances.
Even if assessed in a large sample of pALS, the relationship
between psychological factors and executive functions in such
population cannot be considered fully clarified. Probably,
the investigation about the complexity of factors modulating
executive functions will benefit from the fully control of
psychological variables, verbal-motor components of cognitive
tests and other well-known aspects influencing cognitive
performances (i.e., socio-demographic variables).
Despite the above mentioned limitations, if confirmed by
further investigations and by stronger statistical results, the
observed association between depression and executive functions
could help to better plan both cognitive assessment/training
and psychological interventions in ALS. With regard to the
former, to emphasize the importance of a careful screening
for depression could help to avoid a cognitive involvement
overestimation. Furthermore, the observed correlation could
mask the progression of cognitive involvement as measured in
longitudinal assessments. Such point should be targeted in future
follow-up studies with the ECAS. With regard to psychological
interventions, the explanation about how comorbid cognitive
impairment, as well as other biopsychosocial factors, moderate
both pharmacotherapy and psychotherapy outcomes in ALS
could turn into more tailored and effective interventions.
Actually, due to the poor definition of the influence between
cognitive and psychological aspects in ALS, cognitive alterations
are mostly not considered in psychological interventions in ALS
(Gould et al., 2015). Additionally, the influence of psychotherapy
on cognitive aspects of pALS should be more deeply investigated,
according to recent literature showing an association between
changes in the central nervous systems, i.e., an attenuation in
disease progression, and a concomitant psychological treatment
(Kleinbub et al., 2015).
The presented work could represent an important step toward
the definition of a integrated approach to intervention for pALS,
in accordance with the biopsychosocial model, with the aim to
carefully and more efficiently manage such complex disease.
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